Name- Leucine Rich Bio Pvt Ltd

Inception- 2014

Location- Bengaluru

Industry Domain- Therapeutics (Microbiome)

Founders- Kumar Sankaran (Chief Executive Officer), Prabhath Manjappa (Chief Product Officer) and Dr Debojyoti Dhar (Director)

Total team strength- 9

Total funds raised- Rs 3 crore

Investors- Omphalos Ventures, Bengaluru and an angel investor

Revenue generated since inception- Rs 3.72 crore

Key Highlights-

• South Asia’s first microbiome company having successfully developed and commercialized gut microbiome test called BugSpeaks
• Launched India’s first microbiome data-based nutraceutical product line called Rychbiome
• Filed two patents and many more are on the anvil
• To take BugSpeaks test to Europe and US in the next five years
• To bring in new diagnostics and therapeutics based on the microbiome

Founder Speaks-

"Microbiome has been found to be associated with myriad of diseases. Better research and new developments in the field can help realize the true potential of this domain. Microbiome can play a big role in not only diagnostics but prognosis and therapeutics too! We envision microbiome-based testing to be democratized and it will be soon the “go to test” for many ailments and also for wellness related activities!"

- Dr Debojyoti Dhar, Director, Leucine Rich Bio, Bengaluru